Back to Search Start Over

Incidence, prevalence, and mortality of type 1 diabetes in children and youth in Burkina Faso 2013-2022.

Authors :
Sagna Y
Bagbila WPAH
Sawadogo N
Savadogo PPC
Zoungrana L
Séré L
Yanogo ADR
Saloukou KEM
Zemba D
Zio GU
Zombre YT
Millogo R
Traoré S
Ilboudo A
Bognounou R
Ouedraogo NCJ
Nikiema P
Bengaly S
Gilberte Kyelem C
Guira O
Maniam J
Ogle GD
Ouedraogo MS
Drabo JY
Source :
Diabetes research and clinical practice [Diabetes Res Clin Pract] 2024 Jan; Vol. 207, pp. 111086. Date of Electronic Publication: 2024 Jan 03.
Publication Year :
2024

Abstract

Aim: There are no data on type 1 diabetes (T1D) incidence and prevalence in Burkina Faso. We aimed to determine these in persons aged <25 years (y) since the implementation of Life for a Child (LFAC) program in 2013.<br />Patients and Methods: Data were collected from the prospective program register. Diagnosis of T1D was clinical, based on presentation, abrupt onset of symptomatic hyperglycemia, need for insulin replacement therapy from diagnosis, and no suggestion of other diabetes types.<br />Results: We diagnosed 312 cases of T1D <25y in 2013-2022. Male-to-female ratio was 1:1. T1D incidence <25y per 100,000 population/year increased from 0.08 (CI 95% 0.07-0.60) in 2013 to 0.34 (CI 95% 0.26-0.45) in 2022 (p=0.002). Incidence <15y/y rose from 0.04 (CI 95% 0.01-0.10) to 0.27 (CI 95% 0.18-0.38) per 100,000/year in 2013 and 2022, respectively (p < 0.002). Prevalence per 100,000 population <25y was 0.27 (CI 95% 0.19-0.37) in 2013 and rose to 1.76 (CI 95% 1.546-1.99) in 2022 (p<0.0001). Mortality rate was 20 (CI 95% 13-29.6) per 1,000-person y.<br />Conclusions: There is a low but sharply rising T1D incidence and prevalence rates in children and youth in Burkina Faso since LFAC program implementation. It is very likely this is partly due to improved case detection. Mortality remains substantial.<br />Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.<br /> (Copyright © 2023 Elsevier B.V. All rights reserved.)

Details

Language :
English
ISSN :
1872-8227
Volume :
207
Database :
MEDLINE
Journal :
Diabetes research and clinical practice
Publication Type :
Academic Journal
Accession number :
38181985
Full Text :
https://doi.org/10.1016/j.diabres.2023.111086